FDA OKs Two Blood Tests to Estimate SARS-CoV-2 Antibodies FDA OKs Two Blood Tests to Estimate SARS-CoV-2 Antibodies

The numbers of antibodies can act as a baseline, but the information they yield is limited. The FDA cautions against using the results as an indicator to relax precautions.FDA Approvals
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Infectious Diseases News Alert Source Type: news